Filing Details

Accession Number:
0001209191-19-035509
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-07 16:05:03
Reporting Period:
2019-06-05
Accepted Time:
2019-06-07 16:05:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1446847 Ironwood Pharmaceuticals Inc IRWD Pharmaceutical Preparations (2834) 043404176
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1487179 Julie Mchugh C/o Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2019-06-05 1,500 $11.26 109,337 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.15 to $11.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.